-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: July 2012
Just What the Doctor Ordered: Biotech’s Improved Apple
There’s a lot of buzz right now over the new “Arctic Apple,” genetically engineered to resist browning due to cutting, biting and bruising. The Golden Delicious and Granny Smith apples developed by Okanagan Specialty Fruits Inc. (OSF) are exactly like a conventional apple in every way, except for its improved trait, that will – hopefully – increase apple consumption and popularity. The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (USDA APHIS) recently Read More >
Patent Evergreening in India: Response from the Other Side
Thank you Adriana for commenting on my article Patent “Ever-Greening”: Novartis Confronts Patent Myth in India. Before I respond, here is your full comment: Adriana says: While patients in India may still be able to access a generic form of off-patent imatinib mesylate (Glivec) if Novartis wins their legal challenge (because this “original form” was never patented in India due to India’s patent law not allowing product patents on medicines prior to 2005), a legal Read More >
Silk Improves Vaccine Longevity
Who doesn’t love the feel of silk fabric? Dresses, ties, sofa upholstery- you name it, we can’t keep our hands off it. You may have also heard that silk is an excellent surgical material for sutures, bandages, and implants. But did you know that our favorite fiber may not only patch up the world, but heal it as well? Here’s the problem we face: Many vaccines need to be kept cold in order to work Read More >
Massachusetts Governor and Lawmakers Improve Patient Access
Earlier this week Massachusetts Governor Deval Patrick signed the 2013 budget. Within that budget are two provisions that will ultimately benefit healthcare consumers within the Commonwealth. The first provision was a partial repeal of the Massachusetts gift ban law enacted two years ago. In the words of Governor Patrick, “This narrow change will afford healthcare providers some flexibility to be educated on new clinically relevant products and allow them to stay informed on advancements in Read More >
Senator John Kerry and the 2012 BIO International Convention
One of our scheduled keynote speakers at the 2012 BIO International Convention in Boston was Senator John Kerry of Massachusetts. Unfortunately the Senator was unable to join us as planned when his duties kept him in Washington, DC for votes on important legislation. Senator Kerry has been a strong supporter of biomedical innovation. During the health care reform debate, Senator Kerry strongly supported and fought for a 12-year data exclusivity period for innovative biomedicines and Read More >
